Cargando…

Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer

SIMPLE SUMMARY: Precise staging is key for the optimal management of advanced prostate cancer. PSMA PET-CT and WB-MRI outperform standard imaging technology for staging high-risk prostate cancer, but direct comparison between both modalities is lacking. The primary endpoint of our study was to compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Damme, Julien, Tombal, Bertrand, Collette, Laurence, Van Nieuwenhove, Sandy, Pasoglou, Vassiliki, Gérard, Thomas, Jamar, François, Lhommel, Renaud, Lecouvet, Frédéric E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582508/
https://www.ncbi.nlm.nih.gov/pubmed/34771449
http://dx.doi.org/10.3390/cancers13215286
_version_ 1784597002977280000
author Van Damme, Julien
Tombal, Bertrand
Collette, Laurence
Van Nieuwenhove, Sandy
Pasoglou, Vassiliki
Gérard, Thomas
Jamar, François
Lhommel, Renaud
Lecouvet, Frédéric E.
author_facet Van Damme, Julien
Tombal, Bertrand
Collette, Laurence
Van Nieuwenhove, Sandy
Pasoglou, Vassiliki
Gérard, Thomas
Jamar, François
Lhommel, Renaud
Lecouvet, Frédéric E.
author_sort Van Damme, Julien
collection PubMed
description SIMPLE SUMMARY: Precise staging is key for the optimal management of advanced prostate cancer. PSMA PET-CT and WB-MRI outperform standard imaging technology for staging high-risk prostate cancer, but direct comparison between both modalities is lacking. The primary endpoint of our study was to compare the diagnostic accuracy of both techniques in the detection of lymph node, bone and visceral metastases against a best valuable comparator (BVC), defined as a consensus adjudication of all lesions on the basis of baseline and follow-up imaging, biological and clinical data and histopathologic confirmation when available. Knowing the diagnostic accuracy of both next generation imaging modalities might influence the diagnostic and therapeutic strategy in prostate cancer by tailoring therapy. However, the impact on treatment and patient outcome of an improved detection of metastases has not been determined yet. ABSTRACT: Background: Prostate specific membrane antigen (PSMA) positron emission tomography computed tomography (PET-CT) and whole-body magnetic resonance imaging (WB-MRI) outperform standard imaging technology for the detection of metastasis in prostate cancer (PCa). There are few direct comparisons between both modalities. This paper compares the diagnostic accuracy of PSMA PET-CT and WB-MRI for the detection of metastasis in PCa. One hundred thirty-four patients with newly diagnosed PCa (n = 81) or biochemical recurrence after curative treatment (n = 53) with high-risk features prospectively underwent PSMA PET-CT and WB-MRI. The diagnostic accuracy of both techniques for lymph node, skeletal and visceral metastases was compared against a best valuable comparator (BVC). Overall, no significant difference was detected between PSMA PET-CT and WB-MRI to identify metastatic patients when considering lymph nodes, skeletal and visceral metastases together (AUC = 0.96 (0.92–0.99) vs. 0.90 (0.85–0.95); p = 0.09). PSMA PET-CT, however, outperformed WB-MRI in the subgroup of patients with newly diagnosed PCa for the detection of lymph node metastases (AUC = 0.96 (0.92–0.99) vs. 0.86 (0.79–0.92); p = 0.0096). In conclusion, PSMA PET-CT outperforms WB-MRI for the detection of nodal metastases in primary staging of PCa.
format Online
Article
Text
id pubmed-8582508
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85825082021-11-12 Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer Van Damme, Julien Tombal, Bertrand Collette, Laurence Van Nieuwenhove, Sandy Pasoglou, Vassiliki Gérard, Thomas Jamar, François Lhommel, Renaud Lecouvet, Frédéric E. Cancers (Basel) Article SIMPLE SUMMARY: Precise staging is key for the optimal management of advanced prostate cancer. PSMA PET-CT and WB-MRI outperform standard imaging technology for staging high-risk prostate cancer, but direct comparison between both modalities is lacking. The primary endpoint of our study was to compare the diagnostic accuracy of both techniques in the detection of lymph node, bone and visceral metastases against a best valuable comparator (BVC), defined as a consensus adjudication of all lesions on the basis of baseline and follow-up imaging, biological and clinical data and histopathologic confirmation when available. Knowing the diagnostic accuracy of both next generation imaging modalities might influence the diagnostic and therapeutic strategy in prostate cancer by tailoring therapy. However, the impact on treatment and patient outcome of an improved detection of metastases has not been determined yet. ABSTRACT: Background: Prostate specific membrane antigen (PSMA) positron emission tomography computed tomography (PET-CT) and whole-body magnetic resonance imaging (WB-MRI) outperform standard imaging technology for the detection of metastasis in prostate cancer (PCa). There are few direct comparisons between both modalities. This paper compares the diagnostic accuracy of PSMA PET-CT and WB-MRI for the detection of metastasis in PCa. One hundred thirty-four patients with newly diagnosed PCa (n = 81) or biochemical recurrence after curative treatment (n = 53) with high-risk features prospectively underwent PSMA PET-CT and WB-MRI. The diagnostic accuracy of both techniques for lymph node, skeletal and visceral metastases was compared against a best valuable comparator (BVC). Overall, no significant difference was detected between PSMA PET-CT and WB-MRI to identify metastatic patients when considering lymph nodes, skeletal and visceral metastases together (AUC = 0.96 (0.92–0.99) vs. 0.90 (0.85–0.95); p = 0.09). PSMA PET-CT, however, outperformed WB-MRI in the subgroup of patients with newly diagnosed PCa for the detection of lymph node metastases (AUC = 0.96 (0.92–0.99) vs. 0.86 (0.79–0.92); p = 0.0096). In conclusion, PSMA PET-CT outperforms WB-MRI for the detection of nodal metastases in primary staging of PCa. MDPI 2021-10-21 /pmc/articles/PMC8582508/ /pubmed/34771449 http://dx.doi.org/10.3390/cancers13215286 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Van Damme, Julien
Tombal, Bertrand
Collette, Laurence
Van Nieuwenhove, Sandy
Pasoglou, Vassiliki
Gérard, Thomas
Jamar, François
Lhommel, Renaud
Lecouvet, Frédéric E.
Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
title Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
title_full Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
title_fullStr Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
title_full_unstemmed Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
title_short Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
title_sort comparison of (68)ga-prostate specific membrane antigen (psma) positron emission tomography computed tomography (pet-ct) and whole-body magnetic resonance imaging (wb-mri) with diffusion sequences (dwi) in the staging of advanced prostate cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582508/
https://www.ncbi.nlm.nih.gov/pubmed/34771449
http://dx.doi.org/10.3390/cancers13215286
work_keys_str_mv AT vandammejulien comparisonof68gaprostatespecificmembraneantigenpsmapositronemissiontomographycomputedtomographypetctandwholebodymagneticresonanceimagingwbmriwithdiffusionsequencesdwiinthestagingofadvancedprostatecancer
AT tombalbertrand comparisonof68gaprostatespecificmembraneantigenpsmapositronemissiontomographycomputedtomographypetctandwholebodymagneticresonanceimagingwbmriwithdiffusionsequencesdwiinthestagingofadvancedprostatecancer
AT collettelaurence comparisonof68gaprostatespecificmembraneantigenpsmapositronemissiontomographycomputedtomographypetctandwholebodymagneticresonanceimagingwbmriwithdiffusionsequencesdwiinthestagingofadvancedprostatecancer
AT vannieuwenhovesandy comparisonof68gaprostatespecificmembraneantigenpsmapositronemissiontomographycomputedtomographypetctandwholebodymagneticresonanceimagingwbmriwithdiffusionsequencesdwiinthestagingofadvancedprostatecancer
AT pasoglouvassiliki comparisonof68gaprostatespecificmembraneantigenpsmapositronemissiontomographycomputedtomographypetctandwholebodymagneticresonanceimagingwbmriwithdiffusionsequencesdwiinthestagingofadvancedprostatecancer
AT gerardthomas comparisonof68gaprostatespecificmembraneantigenpsmapositronemissiontomographycomputedtomographypetctandwholebodymagneticresonanceimagingwbmriwithdiffusionsequencesdwiinthestagingofadvancedprostatecancer
AT jamarfrancois comparisonof68gaprostatespecificmembraneantigenpsmapositronemissiontomographycomputedtomographypetctandwholebodymagneticresonanceimagingwbmriwithdiffusionsequencesdwiinthestagingofadvancedprostatecancer
AT lhommelrenaud comparisonof68gaprostatespecificmembraneantigenpsmapositronemissiontomographycomputedtomographypetctandwholebodymagneticresonanceimagingwbmriwithdiffusionsequencesdwiinthestagingofadvancedprostatecancer
AT lecouvetfrederice comparisonof68gaprostatespecificmembraneantigenpsmapositronemissiontomographycomputedtomographypetctandwholebodymagneticresonanceimagingwbmriwithdiffusionsequencesdwiinthestagingofadvancedprostatecancer